Daiichi Sankyo (DSNKY) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 13 250 sessions, September 9, 2025 to September 4, 2026
- Largest daily move
- -11.5% close of July 31, 2026
- 1-year change
- -28% adjusted closes, September 9, 2025 to September 4, 2026
- 5-year change
- -31.2% adjusted closes, September 8, 2021 to September 4, 2026
Company Description
Daiichi Sankyo (OTC Link: DSNKY) is classified in the drug manufacturers - general industry within the Healthcare sector and carries a market capitalization of $33.5B.
DSNKY has declined 26.6% over the past year. Shares last traded at $18.01.
This page collects what Stock Titan holds for DSNKY, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Daiichi Sankyo (DSNKY) stock last closed at $18.01. Over the past 12 months, the stock has lost 26.6%. At a market capitalization of $33.5B, DSNKY is classified as a large-cap stock with approximately 1.8B shares outstanding.
Latest News
Daiichi Sankyo has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, fda approval. View all DSNKY news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Daiichi Sankyo (DSNKY) currently stands at 148.1 thousand shares, down 38.3% from the previous reporting period, representing 0.0% of the float. Since September 2025, short interest has increased by 340.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Daiichi Sankyo (DSNKY) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
DSNKY Company Profile & Sector Positioning
Daiichi Sankyo (DSNKY) operates in the Drug Manufacturers - General industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing DSNKY often look at related companies in the same sector, including Astellas Pharma (ALPMY), Takeda Pharmaceutical Co Ltd (TKPHF), Merck Kgaa (MKKGY), Kyowa Hakko (KYKOY), and Roche Hldg (RHHBY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DSNKY's relative position within its industry.